Skip to content
← Back to this collection

PUBLICATIONS · 19066607

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
2009 Jan 13
First author
Huebner G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Huebner G
      type
      Author
    2. name
      Link H
      type
      Author
    3. name
      Kohne CH
      type
      Author
    4. name
      Stahl M
      type
      Author
    5. name
      Kretzschmar A
      type
      Author
    6. name
      Steinbach S
      type
      Author
    7. name
      Folprecht G
      type
      Author
    8. name
      Bernhard H
      type
      Author
    9. name
      Al-Batran SE
      type
      Author
    10. name
      Schoffski P
      type
      Author
    11. name
      Burkart C
      type
      Author
    12. name
      Kullmann F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Huebner G
      type
      Author
    2. name
      Link H
      type
      Author
    3. name
      Kohne CH
      type
      Author
    4. name
      Stahl M
      type
      Author
    5. name
      Kretzschmar A
      type
      Author
    6. name
      Steinbach S
      type
      Author
    7. name
      Folprecht G
      type
      Author
    8. name
      Bernhard H
      type
      Author
    9. name
      Al-Batran SE
      type
      Author
    10. name
      Schoffski P
      type
      Author
    11. name
      Burkart C
      type
      Author
    12. name
      Kullmann F
      type
      Author
    bibliography ids
    1. nci-bib-48ea6bfc6a42afb39938d95c
    book metadata
    content sha256
    1052c90724fb0108edcc91b49eb7901b636adf6fae8c9012e7a9953080a8bf94
    document type
    citation
    dois
    1. 10.1038/sj.bjc.6604818
    electronic publication date
    display
    2008 Dec 9
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19066607
    immutable id
    pubmed:19066607@1052c90724fb0108edcc91b49eb7901b636adf6fae8c9012e7a9953080a8bf94
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    1
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    44-9
    volume
    100
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19066607
      provenance
      batch id
      27a383f06e5fc3d04fad
      provider
      NCBI PubMed ESummary
      record sha256
      719151e27c9cf896630c3678b2ca05dd15c8e29c8e2c661885a7eb7e55c8db8e
      response sha256
      51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
      retrieved at
      2026-09-09T23:46:24.265787+00:00
      publication date
      display
      2009 Jan 13
      precision
      day
      year
      2009
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19066607/
      title
      Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

      Preserved source evidence · Not medical advice